atb
3 articole · RSS
Capital Market
Antibiotice Iasi Proposes Shareholders Two Profit Distribution Options
State-run pharmaceutical producer Antibiotice Iasi (ATB.RO), has called shareholders to approve the distribution of the RON51.76 million 2025 net profit. The Board proposed two dividend distribution scenarios, both of them with a payment date set for October 2...
Capital Market
EIB To Advise Antibiotice Iasi On Strengthening Corporate Governance And Investment Capability
The European Investment Bank (EIB) will advise Antibiotice SA (ATB.RO), the largest Romanian majority-held pharmaceutical company, on strengthening its corporate governance to support future...
Capital Market
Antibiotice Iasi Invests EUR75M In Production Of Critical Medicines
State-run Antibiotice Iasi (ATB.RO), has started a EUR75 million strategic project to build a research and development center and a new production facility for critical medicines.